These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4201225)

  • 1. Pseudomonas aeruginosa vaccine in cancer patients.
    Young LS; Meyer RD; Armstrong D
    Ann Intern Med; 1973 Oct; 79(4):518-27. PubMed ID: 4201225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia].
    Vetkova LG; Zaĭtsev LG; Khasman EL; Radkevich SA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):14-8. PubMed ID: 3085409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia.
    Haghbin M; Armstrong D; Murphy ML
    Cancer; 1973 Oct; 32(4):761-6. PubMed ID: 4201654
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological failure of Pseudomonas vaccination in patients receiving multiple chemotherapy.
    Bannister P; Mellor J
    J Biol Stand; 1985 Oct; 13(4):321-6. PubMed ID: 3932361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pseudomonas respiratory infection in a surgical intensive care unit.
    Polk HC; Borden S; Aldrete JA
    Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas aeruginosa bacteremia in patients with neoplastic disease.
    Fishman LS; Armstrong D
    Cancer; 1972 Sep; 30(3):764-73. PubMed ID: 4627601
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infections in minks caused by Pseudomonas aeruginosa. Infection and vaccination trials].
    Karlsson KA; Kull KE; Svanholm R
    Nord Vet Med; 1971; 23(7):345-51. PubMed ID: 5004400
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
    Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas vaccine. 3. Evaluation of a polyvalent vaccine.
    De Fajardo CL; Laborde HF
    J Bacteriol; 1968 May; 95(5):1968-9. PubMed ID: 4967780
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic utilization of an antipseudomonas aeruginosa vaccine in a severe burn unit.
    Wassermann D; Schlotterer M; Paul P; Rieu M
    Scand J Plast Reconstr Surg; 1979; 13(1):81-4. PubMed ID: 451484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of experimental studies on Pseudomonas aeruginosa infection].
    Honma Y
    Nihon Saikingaku Zasshi; 1972 Sep; 27(5):629-40. PubMed ID: 4199828
    [No Abstract]   [Full Text] [Related]  

  • 15. Infections with Pseudomonas aeruginosa, Aspergillus species and Mucoraceae.
    Armstrong D
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):297-9. PubMed ID: 823138
    [No Abstract]   [Full Text] [Related]  

  • 16. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
    Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
    Pennington JE
    J Infect Dis; 1974 Nov; 130 Suppl(0):S159-62. PubMed ID: 4213986
    [No Abstract]   [Full Text] [Related]  

  • 20. [An acellular vaccine from Pseudomonas aeruginosa. II. -- Estimate of immuneserum protective effect by measure of bacterial clearance (author's transl)].
    Daoulas-Le Bourdelles F; Berche P; Véron M
    Ann Microbiol (Paris); 1977 Jul; 128B(1):61-71. PubMed ID: 410340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.